Public engagement and clinical trials : new models and disruptive technologies : workshop summary / Victoria Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.

Date:
[2012], ©2012
  • Books

About this work

Description

Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether they are effective and to assess any harm that may arise from treatment. There is growing recognition among many stakeholders that the U.S. clinical trials enterprise is unable to keep pace with the national demand for research results. The IOM, along with the Mount Sinai School of Medicine, held a workshop June 27-28, 2011, to engage stakeholders and experts in a discussion about possible solutions to improve public engagement in clinical trials.

Publication/Creation

Washington, D.C. : National Academies Press, [2012], ©2012.

Physical description

xvi, 124 pages : 1 color illustrations ; 23 cm

Bibliographic information

Includes bibliographical references (p. 85-87).

Contents

Introduction -- Recruitment challenges in clinical trials for different diseases and conditions -- Models for public engagement -- Messages and methods for public engagement -- The media -- Novel clinical trials designs -- The health system's structure and culture -- Toward a patient-centered strategy for clinical trials.

Languages

Where to find it

  • LocationStatus
    Medical Collection
    QV771.4 2012P97p
    Open shelves

Permanent link

Identifiers

ISBN

  • 9780309219297
  • 0309219299